A Monoclonal Antibody Specific for Japanese Encephalitis Virus with High Neutralizing Capability for Inclusion as a Positive Control in Diagnostic Neutralization Tests
- 3 July 2019
- journal article
- research article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 101 (1) , 233-236
Abstract
Japanese encephalitis virus (JEV) is the most common cause of viral encephalitis in Asia, and it is increasingly a global public health concern because of its recent geographic expansion. Although commercial vaccines are available and used in some endemic countries, JEV continues to cause illness, with more than 60,000 cases reported annually. To develop a reproducible positive control antibody useable in diagnosis of JEV infections, murine hybridomas were developed from mice inoculated with a combination of IXIARO JEV vaccine and JEV domain III of the envelope protein (E-DIII). Monoclonal antibodies (MAbs) were characterized for their ability to neutralize virus in vitro. Monoclonal antibody 17BD3-2 was found to be JEV specific and highly neutralizing, with a plaque reduction neutralization test (PRNT)90 endpoint titer of 1.25 μg/mL. The functional epitopes were mapped using virus neutralization escape variants to amino acid residues S309, K312, and G333 in E-DIII. This MAb may be substituted for human immune sera used as a positive control in PRNT for distribution to public health laboratories worldwide in potential future outbreaks of JEV.Keywords
This publication has 18 references indexed in Scilit:
- Immunodominance and Functional Activities of Antibody Responses to Inactivated West Nile Virus and Recombinant Subunit Vaccines in MiceJournal of Virology, 2011
- Genotype-Specific Neutralization and Protection by Antibodies against Dengue Virus Type 3Journal of Virology, 2010
- The Zoonotic Flaviviruses of Southern, South‐Eastern and Eastern Asia, and Australasia: The Potential for Emergent VirusesZoonoses and Public Health, 2009
- Ecology and Geographical Expansion of Japanese Encephalitis VirusAnnual Review of Entomology, 2009
- Non-structural proteins of dengue 2 virus offer limited protection to interferon-deficient mice after dengue 2 virus challengeJournal of General Virology, 2006
- Structural basis of West Nile virus neutralization by a therapeutic antibodyNature, 2005
- Chimeric Dengue 2 PDK-53/West Nile NY99 Viruses Retain the Phenotypic Attenuation Markers of the Candidate PDK-53 Vaccine Virus and Protect Mice against Lethal Challenge with West Nile VirusJournal of Virology, 2005
- Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutantsVirology, 1991
- Molecular Characterization of a Neutralizing Domain of the Japanese Encephalitis Virus Structural GlycoproteinJournal of General Virology, 1989
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975